Position in MRNA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$541,612
+$129,218 QoQ
Shares Held
7,734
-4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#368
of 772 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meeder Advisory Services, Inc. holds $10,646,226 across 17 Biotechnology names. MRNA ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,415 | $3,186,522 | |
| 2 | RPRX |
Royalty Pharma plc
|
19,242 | $1,078,898 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,311 | $817,460 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,922 | $734,512 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
7,660 | $607,361 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
7,734 | $541,612 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,611 | $484,959 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
7,785 | $452,542 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,612 | 7,734 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $412,394 | 8,118 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $212,740 | 7,214 | Shares | Sole | 2026-02-11 | |
| 2024-06-30 | $409,331 | 3,447 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $205,767 | 1,931 | Shares | Sole | 2024-05-07 | |
| 2023-09-30 | $206,270 | 1,997 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $409,333 | 3,369 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $644,114 | 4,194 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $723,509 | 4,028 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||